Zobrazeno 1 - 2
of 2
pro vyhledávání: '"George Blumenschein, Jr"'
Autor:
Muhammad Aminu, Natalie I. Vokes, Maliazurina B. Saad, Hui Li, Lingzhi Hong, Mohamed S. Mohamed, John Boom, Pingjun Chen, Mehmet Altan, Saumil Gandhi, Stephen Swisher, Mara B. Antonoff, Jenny V. Pozadzides, George Blumenschein Jr, Don L. Gibbons, Tina Cascone, Yasir Y. Elamin, Xiuning Le, Marcelo V. Negrao, Ferdinandos Skoulidis, Anne S. Tsao, Janet Tu, J.Jack Lee, Jianjun Zhang, John V. Heymach, Jia Wu
Publikováno v:
Cancer Research. 83:4393-4393
Background: Compared to other well-studied biomarkers, the relationship between overall tumor burden and immune-checkpoint inhibitor (ICI) efficacy is poorly understood. Methods: We identified patients with stage IV NSCLC without EGFR, ALK or ROS1 al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d87e7fbe78fe0573561bf45e62fc08ad
https://doi.org/10.1158/1538-7445.am2023-4393
https://doi.org/10.1158/1538-7445.am2023-4393
Autor:
Xiuning Le, Frederico O. Gleber-Netto, M. Laura. Rubin, Yun Qing, Robyn Du, Merrill Kies, George Blumenschein, Jr, Charles Lu, Faye M. Johnson, Diana Bell, Jeff Lewis, Jiexin Zhang, Lei Feng, Kaye Wilson, Kathrina Marcelo-Lewis, Jing Wang, Lawrence Ginsberg, Maura Gillison, J. Jack. Lee, Funda Meric-Bernstam, Gordon B. Mills, William N. William, Jeffrey N. Myers, Curtis R. Pickering
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research.
Purpose: Neoadjuvant chemotherapy prior to definitive surgery has been utilized widely for locally advanced oral squamous cell carcinoma (OSCC). We evaluated neoadjuvant erlotinib with platinum-docetaxel vs. placebo with platinum-docetaxel in stage I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a40b2d2a5c0b7b263620c189e191748b
https://pubmed.ncbi.nlm.nih.gov/35443062
https://pubmed.ncbi.nlm.nih.gov/35443062